女性头颈癌患者的保险状态、就诊分期与生存情况
该回顾性队列研究基于监测、流行病学和最终结果数据库(2007—2014年),纳入18923例≥18岁确诊为原发性头颈癌的女性,分析就诊分期的发生率趋势及保险状态与分期、生存的关联。结果显示IV期头颈癌发生率上升,医疗补助参保者和无保险者更易晚期就诊且死亡风险更高。
要点
- 2007至2014年女性IV期头颈癌发生率上升,年度百分比变化为1.24(95%CI 0.30, 2.20)。
- 医疗补助参保者(aOR=1.59,95%CI 1.45, 1.74)和无保险者(aOR=1.73,95%CI 1.47, 2.04)更易诊断为晚期(III/IV期)头颈癌。
- 与私人保险者相比,医疗补助参保者(aHR=1.47,95%CI 1.38, 1.56)和无保险者(aHR=1.45,95%CI 1.29, 1.63)全因死亡风险更高。
核心结论
- 自2007年以来,美国女性头颈癌患者晚期就诊的发生率显著上升,无保险或参加医疗补助的患者更可能晚期就诊并更早死亡。
研究设计与样本
- 回顾性队列研究,查询监测、流行病学和最终结果数据库(2007—2014年),纳入18923例≥18岁确诊为恶性原发性头颈癌的女性。
- 使用Joinpoint回归分析估计就诊分期的发生率趋势,使用Fine和Gray比例风险模型估计保险状态与就诊分期对总生存和疾病特异性生存的关联。
主要发现
- IV期头颈癌发生率从2007年至2014年上升1.24%,年度百分比变化=1.24(95%CI 0.30, 2.20)。
- 医疗补助参保者(aOR=1.59,95%CI 1.45, 1.74)和无保险者(aOR=1.73,95%CI 1.47, 2.04)更可能诊断为晚期(III/IV期)头颈癌。
- 与私人保险者相比,医疗补助参保者(aHR=1.47,95%CI 1.38, 1.56)和无保险者(aHR=1.45,95%CI 1.29, 1.63)全因死亡风险更高。
- 与私人保险者相比,医疗补助参保者(aHR=1.34,95%CI 1.24, 1.44)和无保险者(aHR=1.41,95%CI 1.24, 1.60)头颈癌特异性死亡风险更高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Incidence trends and outcomes of head and neck cancer (HNC) among female patients are not well understood. The objective of this study was to estimate incidence trends and quantify the association between health insurance status, stage at presentation, and survival among females with HNC. STUDY DESIGN: Retrospective cohort study. METHODS: The Surveillance, Epidemiology, and End Results database (2007-2014) was queried for females aged ≥18 years diagnosed with a malignant primary head and neck cancer (HNC) (n = 18,923). Incidence trends for stage at presentation were estimated using Joinpoint regression analysis. The association between health insurance status and stage at presentation on overall and disease-specific survival was estimated using Fine and Gray proportional hazards models. RESULTS: Incidence of stage IV HNC rose by 1.24% from 2007 to 2014 (annual percent change = 1.24, 95% CI 0.30, 2.20). Patients with Medicaid (adjusted odds ratio [aOR] = 1.59, 95% confidence interval [CI] 1.45, 1.74) and who were uninsured (aOR = 1.73, 95% CI 1.47, 2.04) were more likely to be diagnosed with advanced stage (stages III/IV) HNC. Similarly, patients with Medicaid (adjusted hazard ratio [aHR] = 1.47, 95% CI 1.38, 1.56) and who were uninsured (aHR =1.45, 95% CI 1.29, 1.63) were more likely to die from any cause compared to privately insured patients. Medicaid (aHR = 1.34, 95% CI 1.24, 1.44) and uninsured (aHR = 1.41, 95% CI 1.24, 1.60) patients also had a greater hazard of HNC-specific deaths compared to privately insured patients. CONCLUSIONS: Incidence of advanced-stage presentation for female HNC patients in the United States has increased significantly since 2007, and patients who are uninsured or enrolled in Medicaid are more likely to present with late stage disease and die earlier. LEVEL OF EVIDENCE: NA Laryngoscope, 130:385-391, 2020.
引用
- Panth N, Simpson MC, Sethi RKV, et al. Insurance status, stage of presentation, and survival among female patients with head and neck cancer. Laryngoscope. 2019. PMID: 30900256. doi:10.1002/lary.27929
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。